Delivery Order SPE2DB22D3301-SPE2DB25FY8RU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,495.60 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,037.52 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- This delivery order, valued at $1,633.77, was awarded on July 30, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL). The contract represents a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $12,563.16 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract employs firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Prevnar 20 syringes (0.5ML) with a ceiling value of $6,535.08. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The contract is being performed at the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $78,798.85 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 vaccine in 0.5ML syringes, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Prevnar 20 syringes (0.5mL) with a ceiling value of $9,802.68. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to be completed by August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,535.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8RUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $81,411.49 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Prevnar 20 delivery under this order contributes to the Defense Health Agency's vaccine procurement needs as part of the broader pharmaceutical support vehicle. The parent IDC represents a comprehensive global pharmaceutical support contract enabling the company to deliver vaccines, medications, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.4k | 7/31/25 |